Shall ChatGPT be banned from naming medicinal products?
Chatbots such as ChatGPT give healthcare-related advice that can jeopardize patients’ lives. If medical device regulation is not yet adapted for Large Language Models (LLM,) the Swiss legislation on advertising medicinal products could result in the software containing a blocklist with the names of medicinal products and not advising on taking medication.
Table of contents
- Introduction
- 1. Limitations of medical device regulations in the EU and Switzerland
- 2. Swiss Legislation on Advertising of Medicinal Products
- 3. ChatGPT-specific reflection under Swiss law
- 4. The limits of the territorial scope of the Swiss legislation
- Conclusion
Loggen Sie sich bitte ein, um den ganzen Text zu lesen.
Es gibt noch keine Kommentare
Votre commentaire sur cet article
Les abonné-e-s à cette revue peuvent prendre part à la discussion. Veuillez vous connecter pour poster des commentaires.
Aucun commentaire